Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Copper Catalyzed Hydroamination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel copper-catalyzed hydroamination method offers high atom economy and mild conditions for scalable pharmaceutical intermediate production.
Patent CN112521289B enables copper-catalyzed synthesis with mild conditions and high atom economy for reliable pharmaceutical intermediate supply chains.